Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




ASCO 2009: Expert Perspective on Breast Cancer
Link ID 16793
Title ASCO 2009: Expert Perspective on Breast Cancer
Url http://www.medscape.com/viewarticle/704519?src=rss
Description Breast cancer expert Dr. Edith A. Perez reviews the most important and potentially practice-changing information presented at ASCO 2009. Medscape Hematology-Oncology
Category Articles > Hematology-Oncology
Keywords
Date Jun 24, 2009
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Hematology-Oncology
1. Catumaxomab Effective in Treating Malignant Ascites
  Catumaxomab represents a new treatment option for patients with intra-abdominal cancers with symptomatic malignant ascites. Medscape Medical News
Category:   Articles > Hematology-Oncology


2. Pazopanib in Sarcoma: Clinically Significant Benefit? Pazopanib in Sarcoma: Clinically Significant B
  The clinical trial in soft tissue sarcoma that was the basis for the recent approval of this indication has now been published. Medscape Medical News
Category:   Articles > Hematology-Oncology


3. SIR 2009: Focal Cryoablation Safe and Effective for Treating Prostate Cancer
  Focal cryoablation is minimally invasive but is as effective as more aggressive therapies in treating prostate cancer, and is associated with lower morbidity. Medscape Medical News
Category:   Articles > Hematology-Oncology


4. National Comprehensive Cancer Network (NCCN) Non-Small Cell Lung Cancer Guideline, Version 2.2008
  Read the most current update to the NCCN Guideline on the treatment of non-small cell lung cancer, posted on Medscape, for your convenience.
Medscape Hematology-Oncology
Category:   Articles > Hematology-Oncology


5. Use of Chemo Assays Outside Clinical Trials Still a No NoUse of Chemo Assays Outside Clinical Trials
  The American Society of Clinical Oncology continues to recommend against the use of chemotherapy sensitivity and resistance assays, except in the setting of a clinical trial. br / iMedscape Medical News/i
Category:   Articles > Hematology-Oncology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS